MARX Biotech Co., Ltd.

NT$4.03As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7731Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR (30.56%)
Div yield 1.43%
ROE 12.45%
Pharmaceutical Retailers
Beta (5Y) 0.63
PE TTM 66.73
TSR TTM 1.51%
Mkt cap NT$2.104B
ROIC (22.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$4.15
3.09%
(82.77%)
Sell 7|10|3|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.04
0.04
0.05
0.05
(0.22%)
11.42%
17.64%
30.74%
RevenueNT$M
136.9
133.9
137.7
139.9
4.42%
2.62%
6.70%
4.24%
Peers (US$63.06M)
Cap (US$)
PE
262.0M
18.33x
62.64M
13.07x
55.07M
—
Capital
TTM
5Y
10Y
Leveragex
0.056
2.257
1.794
EBIT/Intx
0.677
0.131
0.134
Own earn%
(28.84)
17.95
17.95
Sh yield%
17.37
57.69
57.48
Owners
Insiders/Inst%
13.97
30.25
Short interest%
2.68
SBC / revenue%
5.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
3–9
$1 testx
0.4
Incr. ROIC%
2